Market Overview:
The global OTC gastrointestinal products market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of gastrointestinal diseases, rising awareness about over-the-counter (OTC) medications, and growing demand for convenient and affordable treatment options. The global OTC gastrointestinal products market is segmented on the basis of type into H2 receptor antagonists and proton pump inhibitors (PPIs). The proton pump inhibitors segment is expected to grow at a higher CAGR than the H2 receptor antagonists segment during the forecast period. This can be attributed to the high prevalence of acid reflux disease and GERD, which are treated with PPIs. On the basis of application, the global OTC gastrointestinal products market is divided into hospital pharmacies, drug stores, retail stores, and e-commerce. The drug stores segment is expected to account for a major share of this market in 2018 owing to rising consumer demand for convenient treatment options at affordable prices.
Product Definition:
OTC Gastrointestinal Products are over-the-counter medications that are used to treat gastrointestinal problems. These products include antacids, laxatives, and diarrhea treatments. The importance of OTC gastrointestinal products is that they can provide relief from common digestive problems without the need for a prescription.
H2 Receptor Antagonists:
H2 receptor antagonists are drugs that block the action of histamine on H2 receptors present in the gastrointestinal tract. The drug class also includes cimetidine, ranitidine, and nizatidine among others. The growing prevalence of gastric ulcer disease is expected to be a key factor driving market growth over the forecast period.
Proton Pump Inhibitors (PPIs):
Proton pump inhibitors (PPIs) are a group of drugs that decrease the production of stomach acid. The most common type of PPI is Nexium, Prilosec, and Procardia. Other types include Aciphex, Amrix, Diclofenac potassium tablets USP/Nebuprofen citrate tablets USP and Dexilant.
Application Insights:
OTC gastrointestinal products are majorly used in the treatment of functional GI disorders and other diseases. The application segment includes hospital pharmacies, retail stores, e-commerce and drug stores. Hospital pharmacies accounted for the largest share owing to presence of a large number of hospitals and healthcare centers that offer OTC medicines. Retail stores are expected to be fastest growing market as compared to other applications due to increasing awareness about availability of OTC drugs among consumers.
The others segment includes PPI therapy for peptic ulcer disease, acid reflux disease (GERD), gastroesophageal reflux disease (GORD), Zollinger-Ellison syndrome (ZES) and Crohn¢â‚¬â„¢s disease management.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of lifestyle-associated diseases such as obesity and diabetes, rising geriatric population, and high healthcare expenditure. In addition, favorable reimbursement policies for prescription drugs are also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to improving economic conditions in emerging countries such as India and China.
Growth Factors:
- Increasing incidence of gastrointestinal diseases: The incidence of gastrointestinal diseases is increasing globally due to changing lifestyles, unhealthy eating habits, and environmental pollution. This is driving the demand for OTC gastrointestinal products.
- Growing awareness about the benefits of OTC gastrointestinal products: There is a growing awareness among consumers about the benefits of using OTC gastrointestinal products. This is helping to drive the growth of this market.
- Rising demand for natural and herbal-based OTC gastrointestinal products: Consumers are increasingly preferring natural and herbal-based OTC gastrointestinal products due to their perceived safety and efficacy advantages over synthetic drugs. This is propelling the growth of this market segment.
Scope Of The Report
Report Attributes
Report Details
Report Title
OTC Gastrointestinal Products Market Research Report
By Type
H2 Receptor Antagonists, Proton Pump Inhibitors (PPIs)
By Application
Hospital Pharmacies, Drug Stores, Retail Stores, E-Commerce
By Companies
GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer, Bristol-Myers Squibb
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global OTC Gastrointestinal Products Market Report Segments:
The global OTC Gastrointestinal Products market is segmented on the basis of:
Types
H2 Receptor Antagonists, Proton Pump Inhibitors (PPIs)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Drug Stores, Retail Stores, E-Commerce
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Merck
- Novartis
- Bayer
- Pfizer
- Bristol-Myers Squibb
Highlights of The OTC Gastrointestinal Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- H2 Receptor Antagonists
- Proton Pump Inhibitors (PPIs)
- By Application:
- Hospital Pharmacies
- Drug Stores
- Retail Stores
- E-Commerce
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the OTC Gastrointestinal Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OTC gastrointestinal products are medications that are not typically prescribed by a doctor. These products can include over-the-counter medicines, supplements, and food items.
Some of the major companies in the otc gastrointestinal products market are GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer, Bristol-Myers Squibb.
The otc gastrointestinal products market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 OTC Gastrointestinal Products Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 OTC Gastrointestinal Products Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 OTC Gastrointestinal Products Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the OTC Gastrointestinal Products Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global OTC Gastrointestinal Products Market Size & Forecast, 2020-2028
4.5.1 OTC Gastrointestinal Products Market Size and Y-o-Y Growth
4.5.2 OTC Gastrointestinal Products Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 H2 Receptor Antagonists
5.2.2 Proton Pump Inhibitors (PPIs)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Drug Stores
6.2.3 Retail Stores
6.2.4 E-Commerce
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global OTC Gastrointestinal Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 OTC Gastrointestinal Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 H2 Receptor Antagonists
9.6.2 Proton Pump Inhibitors (PPIs)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Drug Stores
9.10.3 Retail Stores
9.10.4 E-Commerce
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 H2 Receptor Antagonists
10.6.2 Proton Pump Inhibitors (PPIs)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Drug Stores
10.10.3 Retail Stores
10.10.4 E-Commerce
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 H2 Receptor Antagonists
11.6.2 Proton Pump Inhibitors (PPIs)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Drug Stores
11.10.3 Retail Stores
11.10.4 E-Commerce
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 H2 Receptor Antagonists
12.6.2 Proton Pump Inhibitors (PPIs)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Drug Stores
12.10.3 Retail Stores
12.10.4 E-Commerce
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 H2 Receptor Antagonists
13.6.2 Proton Pump Inhibitors (PPIs)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Drug Stores
13.10.3 Retail Stores
13.10.4 E-Commerce
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 OTC Gastrointestinal Products Market: Competitive Dashboard
14.2 Global OTC Gastrointestinal Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Merck
14.3.3 Novartis
14.3.4 Bayer
14.3.5 Pfizer
14.3.6 Bristol-Myers Squibb
